Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes

Acta Diabetologica

Volumn 52, Issue 4, 2015, Pages 701-708

  Lu, Jun ^a   Hou, Xuhong ^a   Zhang, Lei ^a   Jiang, Fusong ^a   Hu, Cheng ^a   Bao, Yuqian ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Body mass index; Diabetic retinopathy; Fasting C peptide; Type 2 diabetes

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DRINKING; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN TREATMENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; OPHTHALMOSCOPY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMPLICATION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; OVERWEIGHT; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE;

EID: 84937814433     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0711-y     Document Type: Article

References (45)

1. Garvey WT, Garber AJ, Mechanick JI et al (2014) American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract 20:977–989
2. Hou X, Lu J, Weng J et al (2013) Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLoS ONE 8:e57319
3. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G (2009) Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart 95:454–460
4. Eeg-Olofsson K, Cederholm J, Nilsson PM et al (2009) Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 52:65–73
5. Maric C, Hall JE (2011) Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 170:28–35
6. Logue J, Walker JJ, Leese G et al (2013) Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 36:887–893
7. Gruberg L, Weissman NJ, Waksman R et al (2002) The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39:578–584
8. Karlberg C, Falk C, Green A, Sjolie AK, Grauslund J (2012) Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol 49:263–268
9. Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V (2014) Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study-3. Diabetes Technol Ther [Epub ahead of print]
10. Miyamoto M, Kotani K, Okada K et al (2012) The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. Acta Diabetol 49:63–68
11. Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564
12. Trento M, Passera P, Trevisan M et al (2013) Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study. Acta Diabetol 50:873–877
13. Ding J, Wong TY (2012) Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diabetes Rep 12:346–354
14. Brown JB, Pedula KL, Summers KH (2003) Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 26:2637–2642
15. Diabetes Prevention Program Research Group (2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the diabetes prevention program. Diabet Med 24:137–144
16. Writing Team for the Diabetes C, Complications Trial, Epidemiology of Diabetes I, Complications Research G (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563–2569
17. Keen H, Lee ET, Russell D, Miki E, Bennett PH, Lu M (2001) The appearance of retinopathy and progression to proliferative retinopathy: the WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S22–S30
18. van Leiden HA, Dekker JM, Moll AC et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care 25:1320–1325
19. Cai X, Han X, Zhang S, Luo Y, Chen Y, Ji L (2014) Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese. PLoS ONE 9:e91174
20. Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, Reaven P (2014) Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the veterans affairs diabetes trial (VADT). Diabetologia 57:1124–1131
21. Tolonen N, Hietala K, Forsblom C et al (2013) Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study. J Intern Med 274:469–479
22. Henricsson M, Nystrom L, Blohme G et al (2003) The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based diabetes incidence study in Sweden (DISS). Diabetes Care 26:349–354
23. Zhang L, Krzentowski G, Albert A, Lefebvre PJ (2001) Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24:1275–1279
24. Dirani M, Xie J, Fenwick E et al (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52:4416–4421
25. van Leiden HA, Dekker JM, Moll AC et al (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:245–251
26. Rooney D, Lye WK, Tan G, et al (2014) Body mass index and retinopathy in Asian populations with diabetes mellitus. Acta Diabetol. doi:10.1007/s00592-014-0602-2
27. Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetol 47:209–215
28. Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:2335–2342
29. Gu Y, Wang C, Zheng Y et al (2013) Cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai. PLoS ONE 8:e53411
30. Chinese Diabetes Society (2012) Guidelines for the prevention and treatment of type 2 diabetes in China (2010). Chin J Diabetes 20:81–117
31. (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–xii, 1–253
32. Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682
33. de Mutsert R, Sun Q, Willett WC, Hu FB, van Dam RM (2014) Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study. Am J Epidemiol 179:1353–1365
34. Hou X, Jia W, Bao Y et al (2008) Risk factors for overweight and obesity, and changes in body mass index of Chinese adults in Shanghai. BMC Public Health 8:389
35. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32–42
36. Ahren J, Ahren B, Wierup N (2010) Increased beta-cell volume in mice fed a high-fat diet: a dynamic study over 12 months. Islets 2:353–356
37. Lachin JM, McGee P, Palmer JP (2014) Impact of C-peptide preservation on metabolic and clinical outcomes in the diabetes control and complications trial. Diabetes 63:739–748
38. Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26:832–836
39. Panero F, Novelli G, Zucco C et al (2009) Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care 32:301–305
40. Suzuki K, Watanabe K, Motegi T, Kajinuma H (1989) High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity. Diabetes Res Clin Pract 6:45–52
41. Boz M, Scheen AJ, Gerard PL, Castillo MJ, Lefebvre PJ (1995) Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabete Metab 21:353–359
42. Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2000) Relationship of residual beta-cell function, metabolic control and chronic complications in type 2 diabetes mellitus. Acta Diabetol 37:125–129
43. Genuth SM (1996) Clinical utility of C-peptide measurement in diabetes mellitus. Endocr Pract 2:266–268
44. Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30:803–817
45. Marques RG, Fontaine MJ, Rogers J (2004) C-peptide: much more than a byproduct of insulin biosynthesis. Pancreas 29:231–238